Evidence map›Paper›PMID 40133291›Full record

ArticleNature communications2025

External validation of artificial intelligence for detection of heart failure with preserved ejection fraction.

Ashley P Akerman, Nora Al-Roub, Constance Angell-James, Madeline A Cassidy, Rasheed Thompson, Lorenzo Bosque, Katharine Rainer, William Hawkes, Hania Piotrowska, Paul Leeson and 4 more

Erratum issuedAbstract readValidation Study
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Artificial intelligence in heart failure.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Evaluating the J Wave as a Marker of Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2025
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ashley P AkermanUltromics Ltd, 4630 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, UK.
Nora Al-RoubRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Constance Angell-JamesRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Madeline A CassidyRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Rasheed ThompsonHoward University College of Medicine, Washington, DC, USA.
Lorenzo BosqueDrexel University College of Medicine, Philadelphia, PA, USA.
Katharine RainerRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
William HawkesUltromics Ltd, 4630 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, UK.
Hania PiotrowskaUltromics Ltd, 4630 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, UK.
Paul LeesonUltromics Ltd, 4630 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, UK.ORCID http://orcid.org/0000-0001-9181-9297
Gary WoodwardUltromics Ltd, 4630 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, UK.
Patricia A PellikkaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6800-3521
Ross UptonUltromics Ltd, 4630 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, UK.
Jordan B StromRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA. jstrom@bidmc.harvard.edu.ORCID http://orcid.org/0000-0002-6592-6141

Funding

Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)R01HL169517 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Jordan Blair Strom · 2023 to 2026
$3.1M
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of MedicationsR01AG063937 · NIA · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI GERHARD, TOBIAS · 2020 to 2024
$2.9M
Cardiac Ultrasound Radiomics-Guided Deep Neural Networks for Acute Myocardial Infarction Precision PhenotypingR01HL173998 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Partho P Sengupta · 2025 to 2026
$1.2M
NHLBI NIH HHS R01 HL169517NHLBI NIH HHS R01 HL173998NIA NIH HHS R01 AG063937U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1R01AG063937U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1R01HL173998
6 · The paper itself

Abstract

Artificial intelligence (AI) models to identify heart failure (HF) with preserved ejection fraction (HFpEF) based on deep-learning of echocardiograms could help address under-recognition in clinical practice, but they require extensive validation, particularly in representative and complex clinical cohorts for which they could provide most value. In this study enrolling patients with HFpEF (cases; n = 240), and age, sex, and year of echocardiogram matched controls (n = 256), we compare the diagnostic performance (discrimination, calibration, classification, and clinical utility) and prognostic associations (mortality and HF hospitalization) between an updated AI HFpEF model (EchoGo Heart Failure v2) and existing clinical scores (H2FPEF and HFA-PEFF). The AI HFpEF model and H2FPEF score demonstrate similar discrimination and calibration, but classification is higher with AI than H2FPEF and HFA-PEFF, attributable to fewer intermediate scores, due to discordant multivariable inputs. The continuous AI HFpEF model output adds information beyond the H2FPEF, and integration with existing scores increases correct management decisions. Those with a diagnostic positive result from AI have a two-fold increased risk of the composite outcome. We conclude that integrating an AI HFpEF model into the existing clinical diagnostic pathway would improve identification of HFpEF in complex clinical cohorts, and patients at risk of adverse outcomes.

Indexed as

Artificial IntelligenceHeart FailureStroke VolumeAgedAged, 80 and overEchocardiographyFemaleHospitalizationHumansMaleMiddle AgedPrognosis

Identifiers

PMID40133291
PMCPMC11937413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.